New Zealand: Medicinal Cannabis Costs Set to Tumble After Cheaper Product Gets Green Light

The cost of medicinal cannabis is set to tumble after Associate Health Minister Peter Dunne approved a Canadian pain relief product.

It is estimated the marijuana-based tincture called Tilray will cost at least 50 per cent less than the existing legal product Sativex, a UK mouth spray made by GW Pharma.

Multiple sclerosis sufferer, Dr Huhana Hickey, who applied to use Tilray, said: "I'm so relieved. It's going to save me $700 a month."

The AUT academic says she has spent $9000 on prescriptions since she started taking medicinal cannabis in February. Hickey says the results have been remarkable.

"I'm living my life again. I'm back to work, I am fully-functioning"

She started using the spray to replace pain killers such as morphine, codeine, tramadol and other opiates which she had been prescribed for years.

"At the start I was sceptical I didn't think it was going to work that...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.